Chris Inquires How Secretary Of State Is Monitoring Possible Vaccine Side Effects
To ask the Secretary of State for Health and Social Care, with reference to the oral contribution by the Parliamentary Under Secretary of State for Health and Social Care on 13 December 2022, Official Report column 1092, what steps he is taking to monitor possible side effects from Covid-19 vaccines; whether he has commissioned further research to facilitate better understanding of how to diagnose and treat those who have suffered ill-effects from a Covid-19 vaccine; and when he plans the outcome of that research will be published.
Maria Caulfield The Parliamentary Under-Secretary for Health and Social Care, Parliamentary Under-Secretary (Department for International Trade) (Minister for Women)
The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors safety during the widespread use of a vaccine. For the COVID-19 vaccines, MHRA shares information with other medicines regulators and works with public health partners in reviewing the effectiveness and impact to ensure the benefits continue to outweigh any possible side effects. The results of this monitoring are published monthly and the latest report is available at the following link: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1121345/vaccine-surveillance-report-week-48-2022.pdf
The MHRA also publishes a monthly summary of adverse reactions following COVID-19 vaccination, which is available at the following link: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#update-on-publication-frequency
The National Institute for Health and Care Research has allocated more than £110 million for research on COVID-19 vaccines, including a £1.6 million programme to understand the rare condition of blood clotting with low platelets following vaccination for COVID-19. The study is due to complete in February 2023 and results will be published in due course following peer review.
- ENDS - #110560